Centre for Movement Disorders

Markham, Ontario L6B1C9

0 studies enrolling now · 7 studies all time

What they study most

Dopamine Beta Hydroxylase Deficiency, Huntington's Disease, Multiple System Atrophy, Neurogenic Orthostatic Hypotension, Non-Diabetic Autonomic Neuropathy, Non-diabetic Neuropathy, Parkinson Disease, Parkinson's Disease, Primary Autonomic Failure, Symptomatic Neurogenic Orthostatic Hypotension (NOH)

Studies at this site

• Enroll -HD: A Prospective Registry Study in a Global Huntington's Disease Cohort — Recruiting now
• Parkinson's Foundation Quality Improvement Initiative — Completed
• A Study to Evaluate Fixed Dose Carbidopa/Levodopa/Entacapone Versus Immediate Release Carbidopa/Levodopa — Completed
• Clinical Study of Droxidopa in Patients With Neurogenic Orthostatic Hypotension (NOH) — Completed
• Open-Label Clinical Study of Droxidopa in Patients With Neurogenic Orthostatic Hypotension (NOH) — Completed
• A Fourteen-Week Placebo-Controlled Dose-Response Efficacy and Safety Study of NS 2330 in Early Parkinson's Disease Patients (Study for Proof of Concept in Early Parkinson's Disease of a Triple Reuptake Inhibitor, NS 2330 / SCEPTRE) — Completed
• Efficacy, Safety, and Tolerability of E2007 in Levodopa Treated Parkinson's Disease Patients With Motor Fluctuations — Completed